Results 221 to 230 of about 3,474,042 (288)

Small‐Bowel Impaction Caused by Mechanical Interlocking Between Duodenal Metal and Biliary Plastic Stents

DEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Duodenal self‐expandable metal stents (SEMS) are widely used to treat malignant gastric outlet obstruction (GOO). However, stent migration is a well‐known complication. We report a rare case of small‐bowel impaction caused by the migration of a duodenal SEMS with a biliary plastic stent (PS).
Shinsuke Otagiri, Ryo Sugiura, Masataka Wada, Asako Nomura, Hiroki Egami, Kento Wakabayashi, Kenta Fujihata, Takehiko Katsurada, Satoshi Hirano, Naoya Sakamoto   +9 more
wiley   +1 more source

Evaluation of Additional Treatment for Residual Cases After Endoscopic Papillectomy of Duodenal Ampullary Tumors

DEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Background and Aims This study aimed to assess the prognosis and outcomes of additional treatment for residual adenocarcinoma and adenoma following endoscopic papillectomy (EP) for ampullary tumors. Methods Of 191 patients who underwent EP, 43 with adenocarcinoma or adenoma and either positive or unknown pathological margins were included ...
Yusuke Kurita, Keiki Nagai, Noriki Kasuga, Kensuke Kubota, Yuji Fujita, Yusuke Sekino, Hiroki Uechi, Yuji Koyama, Shintaro Tsujikawa, Shota Matsumoto, Shigeki Tamura, Yu Honda, Shin Yagi, Takeshi Iizuka, Sho Hasegawa, Takamitsu Sato, Kunihiro Hosono, Noritoshi Kobayashi, Yuki Honma, Ryusei Matsuyama, Jotaro Harada, Masato Yoneda, Satoshi Fujii, Itaru Endo, Atsushi Nakajima   +24 more
wiley   +1 more source

Precision chemotherapy in biliary tract cancer moving from empiric intensification to biomarker-guided treatment: Editorial on "Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer". [PDF]

Clin Mol Hepatol
Lee SH, Kaseb AO, Lee JS.
europepmc   +1 more source

Deep molecular profiling of biliary tract cancer uncovers novel biological mechanisms and therapeutic opportunities. [PDF]

ESMO Open
Nichetti F, Hoffmeister P, Korell F, Huellein J, Uhrig S, Rübsam M, Schwab M, Teleanu MV, Jenzer M, Kreutzfeld S, Horak P, Konietzke P, Glimm H, Heining C, Rieke D, Kindler T, Springfeld C, Heilig CE, Hübschmann D, Fröhling S, Köhler BC.   +20 more
europepmc   +1 more source

Feasibility of Comprehensive Genomic Profiling for Biliary Tract Cancer Using Transpapillary Biopsy Samples: A Prospective Study. [PDF]

J Hepatobiliary Pancreat Sci
Miyamoto K, Matsumoto K, Ohara T, Fujisawa M, Inoue H, Sato R, Matsumi A, Fujii Y, Uchida D, Otsuka M.   +9 more
europepmc   +1 more source

Overcoming heterogeneity and immunosuppression: novel strategies in adoptive therapy for biliary tract cancer. [PDF]

Front Immunol
Zhu Y, Xiong G, Guan M, Sun D, Guo Y, Peng J, Zhu H.   +6 more
europepmc   +1 more source

Propensity Score Analysis of Second-Line Chemotherapy Outcome in Advanced Biliary Tract Cancer. [PDF]

J Clin Med
Thanasombunsukh K, Charoentum C, Tantraworasin A, Khorana J.   +3 more
europepmc   +1 more source

Advancing systemic therapy for biliary tract cancer: current strategies and emerging paradigms. [PDF]

Front Oncol
Choucair K, Chamseddine S, Azmi A, Philip PA.   +3 more
europepmc   +1 more source